文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

重症监护室机械通气期间消化道选择性去污染

Selective Decontamination of the Digestive Tract during Ventilation in the ICU.
PubMed 文献 · N Engl J Med · 2025-10-29
一句话结论在澳大利亚和加拿大26个ICU中,机械通气患者接受消化道选择性去污染(SDD)与标准治疗相比,90天院内死亡无显著差异(27.9% vs 29.5%,OR 0.94,95%CI 0.84–1.05,P=0.27)。

该研究将澳大利亚和加拿大的ICU随机分配为使用SDD或继续标准治疗,各两个12个月周期,纳入9289例机械通气患者进行随机试验,另10711例ICU患者纳入观察性生态学评估。SDD组在通气期间接受特定口腔和胃部抗菌干预,入组后前4天接受静脉抗生素。主要终点90天全因院内死亡在SDD组27.9% vs 标准治疗组29.5%(OR 0.94,95%CI 0.84–1.05,P=0.27),无显著差异。新发血流感染4.9% vs 6.8%(调整均差-1.30个百分点,95%CI -2.55至-0.05),抗生素耐药菌培养阳性16.8% vs 26.8%(调整均差-9.60个百分点,95%CI -12.40至-6.80)。生态学评估中SDD对新发抗生素耐药菌的非劣效性未获证实。

要点

  • 在26个ICU、9289例机械通气患者中,SDD组90天院内死亡27.9%(1175/4215)vs 标准治疗组29.5%(1494/5065),OR 0.94(95%CI 0.84–1.05,P=0.27),无显著差异。
  • SDD组新发血流感染4.9% vs 标准治疗组6.8%,调整均差-1.30个百分点(95%CI -2.55至-0.05)。
  • SDD组抗生素耐药菌培养阳性16.8% vs 标准治疗组26.8%,调整均差-9.60个百分点(95%CI -12.40至-6.80)。
  • 生态学评估中,SDD对新发抗生素耐药菌的非劣效性未获证实(非劣效界值2个百分点)。
  • 不良事件:SDD组12例(0.3%)报告与SDD或标准治疗相关的不良事件,标准治疗组0例;严重不良事件分别为47例(1.1%)和59例(1.2%)。

适用人群与场景

  • 澳大利亚和加拿大26个ICU中接受机械通气的危重患者纳入随机试验(9289例);同一ICU内所有其他患者纳入观察性生态学评估(10711例)。

处置流程与药物剂量

  • SDD组在通气期间接受特定口腔和胃部抗菌干预,入组后前4天接受静脉抗生素;标准治疗组继续常规治疗。

研究设计与关键结果

  • 研究类型:在澳大利亚和加拿大26个ICU进行的随机试验(ICU层面随机分配为SDD或标准治疗,各两个12个月周期)联合观察性生态学评估;随机试验纳入9289例机械通气患者,生态学评估纳入10711例。
  • 主要终点:90天全因院内死亡,SDD组27.9%(1175/4215)vs 标准治疗组29.5%(1494/5065),OR 0.94(95%CI 0.84–1.05,P=0.27),无显著差异。
  • 次要终点:新发血流感染SDD组4.9% vs 标准治疗组6.8%,调整均差-1.30个百分点(95%CI -2.55至-0.05);抗生素耐药菌培养阳性SDD组16.8% vs 标准治疗组26.8%,调整均差-9.60个百分点(95%CI -12.40至-6.80)。
  • 生态学评估:SDD对新发抗生素耐药菌的非劣效性未获证实(非劣效界值2个百分点)。
  • 不良事件:与SDD或标准治疗相关的不良事件SDD组12例(0.3%)vs 标准治疗组0例;严重不良事件SDD组47例(1.1%)vs 标准治疗组59例(1.2%)。

证据类型、等级与局限

  • 证据类型:随机试验联合观察性生态学评估;由澳大利亚国家健康与医学研究委员会和加拿大健康研究院资助;ClinicalTrials.gov注册号NCT02389036。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在危重机械通气患者中,SDD与标准治疗相比未降低90天院内死亡发生率(27.9% vs 29.5%,OR 0.94,95%CI 0.84–1.05,P=0.27)。
  • SDD组新发血流感染和抗生素耐药菌培养阳性比例低于标准治疗组,但生态学评估中SDD对新发抗生素耐药菌的非劣效性未获证实。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Whether selective decontamination of the digestive tract (SDD) reduces mortality among patients undergoing mechanical ventilation and whether it adversely affects microbial ecology in the intensive care unit (ICU) remain unclear. In an earlier analysis of data from Australia, SDD did not result in a lower incidence of in-hospital death than standard care, but data from the full international trial are needed.

METHODS: We randomly assigned ICUs in Australia and Canada to use SDD or to continue standard care for two 12-month periods in patients undergoing mechanical ventilation. Patients in the SDD group received specific oral and gastric antimicrobial interventions for the duration of ventilation and an intravenous antibiotic agent for the first 4 days after enrollment. All other patients in the ICU were included in an observational ecologic assessment. Previously reported data from Australia are now combined with data from Canada. The primary outcome was in-hospital death from any cause at 90 days. The secondary clinical outcomes, assessed at 90 days, were death in the ICU and the number of days alive and free of mechanical ventilation, ICU admission, and hospitalization. Microbiologic secondary outcomes included new positive cultures for bloodstream infections and antibiotic-resistant organisms. For the ecologic assessment, the microbiologic outcomes were tested for noninferiority (noninferiority margin, 2 percentage points).

RESULTS: In this trial involving 20,000 patients in 26 ICUs, 9289 patients were enrolled in the randomized trial and 10,711 were included in the ecologic assessment. At 90 days, 1175 of 4215 patients (27.9%) in the SDD group and 1494 of 5065 (29.5%) in the standard-care group had died before hospital discharge (odds ratio, 0.94; 95% confidence interval [CI], 0.84 to 1.05; P = 0.27). New bloodstream infections occurred in 4.9% of the patients in the SDD group and in 6.8% of those in the standard-care group (adjusted mean difference, -1.30 percentage points; 95% CI, -2.55 to -0.05); antibiotic-resistant organisms were cultured in 16.8% and 26.8%, respectively (adjusted mean difference, -9.60 percentage points; 95% CI, -12.40 to -6.80). In the ecologic assessment, noninferiority of SDD was not confirmed for the development of new antibiotic-resistant organisms. Adverse events considered to be related to SDD or standard care were reported in 12 patients (0.3%) in the SDD group and in no patients in the standard-care group. Serious adverse events occurred in 47 patients (1.1%) and 59 patients (1.2%), respectively.

CONCLUSIONS: Among critically ill patients undergoing mechanical ventilation, SDD did not result in a lower incidence of in-hospital death than standard care. (Funded by the National Health and Medical Research Council of Australia and the Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT02389036.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Cuthbertson BH, Billot L, Campbell MK, et al. Selective Decontamination of the Digestive Tract during Ventilation in the ICU. N Engl J Med. 2025. PMID: 41159880. doi:10.1056/NEJMoa2506398

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。